Genetische Prädisposition für unilaterale Vestibularisschwannome:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
Freiburg im Breisgau
[2022]
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
| Beschreibung: | 68 Seiten Illustrationen, Diagramme 30 cm |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV048925890 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 230503s2022 gw a||| m||| 00||| ger d | ||
| 015 | |a 23,H04 |2 dnb | ||
| 016 | 7 | |a 1281026972 |2 DE-101 | |
| 020 | |c Broschur | ||
| 035 | |a (OCoLC)1362479750 | ||
| 035 | |a (DE-599)KXP1831488957 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c XA-DE | ||
| 049 | |a DE-355 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |a 610 |2 sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 100 | 1 | |a Neuhold, Alexander |e Verfasser |0 (DE-588)1278584080 |4 aut | |
| 245 | 1 | 0 | |a Genetische Prädisposition für unilaterale Vestibularisschwannome |c vorgelegt von Raimund Alexander Neuhold |
| 264 | 1 | |a Freiburg im Breisgau |c [2022] | |
| 300 | |a 68 Seiten |b Illustrationen, Diagramme |c 30 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 502 | |b Dissertation |c Albert-Ludwigs-Universität Freiburg im Breisgau |d 2022 | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 856 | 4 | 2 | |m B:DE-101 |q application/pdf |u https://d-nb.info/1281026972/04 |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034189927&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034189927 | ||
| 883 | 0 | |8 1\p |a emakn |c 0,06987 |d 20230222 |q DE-101 |u https://d-nb.info/provenance/plan#emakn | |
| 883 | 2 | |8 2\p |a dnb |d 20230302 |q DE-101 |u https://d-nb.info/provenance/plan#dnb | |
Datensatz im Suchindex
| _version_ | 1804185112030478336 |
|---|---|
| adam_text | INHALTSVERZEICHNIS
INHALTSVERZEICHNIS
.....................................................................................................................................
II
ABKUERZUNGSVERZEICHNIS
.............................................................................................................................
1
ABBILDUNGSVERZEICHNIS
.............................................................................................................................
2
T
ABELLENVERZEICHNIS
..................................................................................................................................
3
1.
ZIELSETZUNG
...........................................................................................................................................
4
2.
EINLEITUNG
..............................................................................................................................................
5
2.1
VESTIBULARISSCHWANNOM
..................................................................................................................
5
2.1.1
EPIDEMIOLOGIE
.............................................................................................................................
6
2.1.2
PATHOGENESE
UND
LOKALISATION
.....................................................................................................
6
2.1.3
KLINIK
..........................................................................................................................................
7
2.1.4
DIAGNOSTIK
...................................................................................................................................
8
2.1.5
AETIOLOGIE
......................................................................................................................................
9
2.1.6
THERAPIE
......................................................................................................................................
10
2.1.6.1
CHIRURGISCHE
THERAPIE
........................................................................................................
10
2.1.6.2
STRAHLENTHERAPIE
..................................................................................................................
11
2.1.6.3
VERLAUFSKONTROLLE
................................................................................................................
12
2.2
GENETIK
UND
MOLEKULARE
MECHANISMEN
........................................................................................
13
2.2.1
MMPS/MATRIX
METALLOPROTEINASEN
.........................................................................................
13
2.2.2
TISSUE
INHIBITOR
OF
METALLOPROTEINASE
3
/
TIMP3
..................................................................
14
2.2.3
CAVEOLIN
1/
CAVI
.................................................................................................................
16
2.2.4
LOH
ANALYSEN
.......................................................................................................................
18
3.
MATERIAL
UND
METHODEN
......................................................................................................................
19
3.1
MATERIAL
.........................................................................................................................................
19
3.1.1
PROBEN
...................................................................................................................................
19
3.1.2
PRIMER
....................................................................................................................................
19
3.1.3
LOSS
OF
HETEROZYGOSITY-MARKER
............................................................................................
21
3.1.4
INTRON/EXON-STRUKTUR
.............................................................................................................
23
3.1.5
CHEMIKALIEN
UND
REAGENZIEN
...............................................................................................
24
3.1.6
KITS
.........................................................................................................................................
24
3.2.7
GERAETE
.....................................................................................................................................
25
3.2.8
PROGRAMME
UND
FEATURES
.......................................................................................................
25
3.2
METHODEN
......................................................................................................................................
25
3.2.1
DNA-PRAEPARATION
...................................................................................................................
25
3.2.2
PHOTOMETRIE
...........................................................................................................................
26
3.2.3
PCR
ZUR
FRAGMENTVERVIELFAELTIGUNG
........................................................................................
26
3.2.4
GELELEKTROPHORESE
..................................................................................................................
27
3.2.5
REINIGUNG
DES
PCR-PRODUKTS
................................................................................................
28
3.2.6
SEQUENZIERUNG
DER
DNA-FRAGMENTE
......................................................................................
28
3.2.7
SEQUENZABGLEICH
UND
PATHOGENITAETSPRUEFUNG
.........................................................................
30
3.2.8
PATHOGENITAETSPRUEFUNG
.............................................................................................................
30
3.2.9
STATITISCHE
METHODEN
.............................................................................................................
30
4.
ERGEBNISSE
...........................................................................................................................................
32
4.1
PATIENTENKOLLEKTIV
.........................................................................................................................
32
4.2
KLINISCHE
DATEN
............................................................................................................................
32
4.3
DNA-SEQUENZIERUNG
....................................................................................................................
33
4.3.1
CAVEOLIN
1
.............................................................................................................................
33
4.3.2
TIMP3
....................................................................................................................................
33
4.4
LOH-ANALYSEN
.............................................................................................................................
38
4.4.1
TUMORGROESSE
...........................................................................................................................
38
4.4.2
DIAGNOSEALTER
.........................................................................................................................
39
4.4.3
KLINISCHE
SYMPTOME:
HOERMINDERUNG,
TINNITUS
UND
SCHWINDEL
...........................................
40
4.4.4
THERAPIE
.................................................................................................................................
43
5.
DISKUSSION
...........................................................................................................................................
45
5.1
SEQUENZIERUNG
..............................................................................................................................
45
5.1.1
CAVEOLIN
1
.............................................................................................................................
45
5.1.2
TIMP3
...................................................................................................................................
47
5.2
LOSS
OF
HETEROZYGOSITY
......................................................................................................,..........
48
5.2.1
KLINISCHE
DATEN
.....................................................................................................................
49
5.3
ALLGEMEINEN
LIMITATIONEN
............................................................................................................
50
5.4
FAZIT
UND
IMPLIKATIONEN
FUER
THEORIE
UND
PRAXIS
..........................................................................
52
6.
ZUSAMMENFASSUNG
..............................................................................................................................
54
7.
LITERATURVERZEICHNIS
............................................................................................................................
55
8.
LEBENSLAUF
...........................................................................................................................................
65
9.
EIDESSTATTLICHE
VERSICHERUNG
..............................................................................................................
67
10.
DANKSAGUNG
......................................................................................................................................
68
|
| adam_txt |
INHALTSVERZEICHNIS
INHALTSVERZEICHNIS
.
II
ABKUERZUNGSVERZEICHNIS
.
1
ABBILDUNGSVERZEICHNIS
.
2
T
ABELLENVERZEICHNIS
.
3
1.
ZIELSETZUNG
.
4
2.
EINLEITUNG
.
5
2.1
VESTIBULARISSCHWANNOM
.
5
2.1.1
EPIDEMIOLOGIE
.
6
2.1.2
PATHOGENESE
UND
LOKALISATION
.
6
2.1.3
KLINIK
.
7
2.1.4
DIAGNOSTIK
.
8
2.1.5
AETIOLOGIE
.
9
2.1.6
THERAPIE
.
10
2.1.6.1
CHIRURGISCHE
THERAPIE
.
10
2.1.6.2
STRAHLENTHERAPIE
.
11
2.1.6.3
VERLAUFSKONTROLLE
.
12
2.2
GENETIK
UND
MOLEKULARE
MECHANISMEN
.
13
2.2.1
MMPS/MATRIX
METALLOPROTEINASEN
.
13
2.2.2
TISSUE
INHIBITOR
OF
METALLOPROTEINASE
3
/
TIMP3
.
14
2.2.3
CAVEOLIN
1/
CAVI
.
16
2.2.4
LOH
ANALYSEN
.
18
3.
MATERIAL
UND
METHODEN
.
19
3.1
MATERIAL
.
19
3.1.1
PROBEN
.
19
3.1.2
PRIMER
.
19
3.1.3
LOSS
OF
HETEROZYGOSITY-MARKER
.
21
3.1.4
INTRON/EXON-STRUKTUR
.
23
3.1.5
CHEMIKALIEN
UND
REAGENZIEN
.
24
3.1.6
KITS
.
24
3.2.7
GERAETE
.
25
3.2.8
PROGRAMME
UND
FEATURES
.
25
3.2
METHODEN
.
25
3.2.1
DNA-PRAEPARATION
.
25
3.2.2
PHOTOMETRIE
.
26
3.2.3
PCR
ZUR
FRAGMENTVERVIELFAELTIGUNG
.
26
3.2.4
GELELEKTROPHORESE
.
27
3.2.5
REINIGUNG
DES
PCR-PRODUKTS
.
28
3.2.6
SEQUENZIERUNG
DER
DNA-FRAGMENTE
.
28
3.2.7
SEQUENZABGLEICH
UND
PATHOGENITAETSPRUEFUNG
.
30
3.2.8
PATHOGENITAETSPRUEFUNG
.
30
3.2.9
STATITISCHE
METHODEN
.
30
4.
ERGEBNISSE
.
32
4.1
PATIENTENKOLLEKTIV
.
32
4.2
KLINISCHE
DATEN
.
32
4.3
DNA-SEQUENZIERUNG
.
33
4.3.1
CAVEOLIN
1
.
33
4.3.2
TIMP3
.
33
4.4
LOH-ANALYSEN
.
38
4.4.1
TUMORGROESSE
.
38
4.4.2
DIAGNOSEALTER
.
39
4.4.3
KLINISCHE
SYMPTOME:
HOERMINDERUNG,
TINNITUS
UND
SCHWINDEL
.
40
4.4.4
THERAPIE
.
43
5.
DISKUSSION
.
45
5.1
SEQUENZIERUNG
.
45
5.1.1
CAVEOLIN
1
.
45
5.1.2
TIMP3
.
47
5.2
LOSS
OF
HETEROZYGOSITY
.,.
48
5.2.1
KLINISCHE
DATEN
.
49
5.3
ALLGEMEINEN
LIMITATIONEN
.
50
5.4
FAZIT
UND
IMPLIKATIONEN
FUER
THEORIE
UND
PRAXIS
.
52
6.
ZUSAMMENFASSUNG
.
54
7.
LITERATURVERZEICHNIS
.
55
8.
LEBENSLAUF
.
65
9.
EIDESSTATTLICHE
VERSICHERUNG
.
67
10.
DANKSAGUNG
.
68 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Neuhold, Alexander |
| author_GND | (DE-588)1278584080 |
| author_facet | Neuhold, Alexander |
| author_role | aut |
| author_sort | Neuhold, Alexander |
| author_variant | a n an |
| building | Verbundindex |
| bvnumber | BV048925890 |
| ctrlnum | (OCoLC)1362479750 (DE-599)KXP1831488957 |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01635nam a2200397 c 4500</leader><controlfield tag="001">BV048925890</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">230503s2022 gw a||| m||| 00||| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">23,H04</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1281026972</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="c">Broschur</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1362479750</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1831488957</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Neuhold, Alexander</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1278584080</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Genetische Prädisposition für unilaterale Vestibularisschwannome</subfield><subfield code="c">vorgelegt von Raimund Alexander Neuhold</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Freiburg im Breisgau</subfield><subfield code="c">[2022]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">68 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">30 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Albert-Ludwigs-Universität Freiburg im Breisgau</subfield><subfield code="d">2022</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">https://d-nb.info/1281026972/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034189927&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034189927</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,06987</subfield><subfield code="d">20230222</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="2" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">dnb</subfield><subfield code="d">20230302</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#dnb</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV048925890 |
| illustrated | Illustrated |
| index_date | 2024-07-03T21:55:59Z |
| indexdate | 2024-07-10T09:50:03Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034189927 |
| oclc_num | 1362479750 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 68 Seiten Illustrationen, Diagramme 30 cm |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| record_format | marc |
| spelling | Neuhold, Alexander Verfasser (DE-588)1278584080 aut Genetische Prädisposition für unilaterale Vestibularisschwannome vorgelegt von Raimund Alexander Neuhold Freiburg im Breisgau [2022] 68 Seiten Illustrationen, Diagramme 30 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Albert-Ludwigs-Universität Freiburg im Breisgau 2022 (DE-588)4113937-9 Hochschulschrift gnd-content B:DE-101 application/pdf https://d-nb.info/1281026972/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034189927&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p emakn 0,06987 20230222 DE-101 https://d-nb.info/provenance/plan#emakn 2\p dnb 20230302 DE-101 https://d-nb.info/provenance/plan#dnb |
| spellingShingle | Neuhold, Alexander Genetische Prädisposition für unilaterale Vestibularisschwannome |
| subject_GND | (DE-588)4113937-9 |
| title | Genetische Prädisposition für unilaterale Vestibularisschwannome |
| title_auth | Genetische Prädisposition für unilaterale Vestibularisschwannome |
| title_exact_search | Genetische Prädisposition für unilaterale Vestibularisschwannome |
| title_exact_search_txtP | Genetische Prädisposition für unilaterale Vestibularisschwannome |
| title_full | Genetische Prädisposition für unilaterale Vestibularisschwannome vorgelegt von Raimund Alexander Neuhold |
| title_fullStr | Genetische Prädisposition für unilaterale Vestibularisschwannome vorgelegt von Raimund Alexander Neuhold |
| title_full_unstemmed | Genetische Prädisposition für unilaterale Vestibularisschwannome vorgelegt von Raimund Alexander Neuhold |
| title_short | Genetische Prädisposition für unilaterale Vestibularisschwannome |
| title_sort | genetische pradisposition fur unilaterale vestibularisschwannome |
| topic_facet | Hochschulschrift |
| url | https://d-nb.info/1281026972/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034189927&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT neuholdalexander genetischepradispositionfurunilateralevestibularisschwannome |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis